₹3058.65 -32.7 -1.1%
Last Trade - 26/02/21
| Market Cap | £4.34bn |
| Enterprise Value | £4.64bn |
| Revenue | £1.04bn |
| Position in Universe | 86th / 3056 |
| Industry | Market | |
|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
| Year End 31st Mar | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021E | 2022E | CAGR / Avg | |
|---|---|---|---|---|---|---|---|---|---|---|
| 51,785 | 62,147 | 72,557 | 82,435 | 96,174 | 112,468 | 105,801 | 132,224 | +16.8% | ||
| +4.0 | -33.9 | +1.3 | -45.0 | +93.0 | +38.0 | -82.0 | +1,041 | |||
|
x
|
||||||||||
| Profitability | ||||||||||
|
%
|
||||||||||
|
%
|
||||||||||
|
%
|
||||||||||
| Cashflow | ||||||||||
| Dividends | ||||||||||
| Balance Sheet | ||||||||||
|
m
|
||||||||||
|
m
|
||||||||||
|
m
|
||||||||||
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing % | |||
| Net Gearing % | |||
| Cash / Assets % |
| Liquidity (ttm) | ||
|---|---|---|
| Curr. Ratio | ||
| Quick Ratio | ||
| Interest Cov. | ||
| Efficiency (ttm) | ||
|---|---|---|
| Asset Turnover | ||
| Recs Turnover | ||
| Stock Turnover | ||
| Latest interim period vs. prior period | Industry | Market |
|---|---|---|
|
|
|
|
|
|
|
| 3yr Compound Annual Growth Rate | Industry | Market |
|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
Revenue
Net Income
Normalised EPS
PE Ratio Range
Dividend Yield Range
|
Price Target:
( below Price)
|
31st Dec 2021
|
31st Dec 2022
|
||||
|---|---|---|---|---|---|---|
| Est. Long Term Growth Rate: |
Net Profit () |
EPS () |
DPS () |
Net Profit () |
EPS () |
DPS () |
| Consensus Estimate | ||||||
| 1m Change | ||||||
| 3m Change | ||||||
Apollo Hospitals Enterprise Limited is a healthcare provider. The Company is engaged in offering healthcare services and operating standalone pharmacies. The Company's segments include Healthcare, Pharmacy and Others. The Healthcare segment consists of hospitals, hospital-based pharmacies, and projects and consultancy services. Its tertiary care hospitals provide care in over 50 specialties, including cardiac sciences, oncology, neurosciences, critical care, orthopedics, radiology, gastroenterology and transplant. The tertiary care hospitals has over 9,550 beds across approximately 70 locations, over 2,330 pharmacies, approximately 170 primary care and diagnostic clinics, and over 150 telemedicine units across approximately 10 countries. The Company also provides project consultancy services, health insurance services, education and training programs, and research services. It also operates birthing centers, day surgery centers and dental clinics.
| Last Annual | March 31st, 2020 |
| Last Interim | December 31st, 2020 |
| Incorporated | December 5, 1979 |
| Public Since | May 23, 1995 |
| No. of Shareholders: | 56,090 |
| No. of Employees: | 62,939 |
| Sector | Healthcare |
| Industry | Healthcare Providers & Services |
| Index | S&P BSE 100 , |
| Exchange | National Stock Exchange of India |
| Shares in Issue | 143,694,657 |
| Free Float | (0.0%) |
| Eligible for |
ISAs
SIPPs
|
| Address | No 55,Ali Towers Greams Road Thousand Lights, CHENNAI, 600006, India |
| Web | https://www.apollohospitals.com/ |
| Phone | +91 44 28290956 |
| Contact | () |
| Auditors | Deloitte Haskins & Sells LLP |
As of 26/02/21, shares in Apollo Hospitals Enterprise are trading at ₹3058.65, giving the company a market capitalisation of £4.34bn. This share price information is delayed by 15 minutes.
Shares in Apollo Hospitals Enterprise are currently trading at ₹3058.65 and the price has moved by 74.93% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Apollo Hospitals Enterprise price has moved by 35.95% over the past year.
Of the analysts with advisory recommendations for Apollo Hospitals Enterprise, there are there are currently 3 "buy" , 1 "hold" and 1 "sell" recommendations. The overall consensus recommendation for Apollo Hospitals Enterprise is Hold. You can view the full broker recommendation list by unlocking its StockReport.
Apollo Hospitals Enterprise is scheduled to issue upcoming financial results on the following dates:
The Apollo Hospitals Enterprise dividend yield is 0.09% based on the trailing twelve month period.
Last year, Apollo Hospitals Enterprise paid a total dividend of 2.75, and it currently has a trailing dividend yield of 0.09%. Looking ahead, Apollo Hospitals Enterprise has not announced an ex-dividend date yet.
Apollo Hospitals Enterprise has yet to annouce their ex-dividend date. The historic dividend yield on Apollo Hospitals Enterprise shares is currently 0.09%.
To buy shares in Apollo Hospitals Enterprise you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
Shares in Apollo Hospitals Enterprise are currently trading at ₹3058.65, giving the company a market capitalisation of £4.34bn.
Here are the trading details for Apollo Hospitals Enterprise:
Based on an overall assessment of its quality, value and momentum, Apollo Hospitals Enterprise is currently classified as a High Flyer. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Shares in Apollo Hospitals Enterprise are currently priced at ₹3058.65. At that level they are trading at 3.82% premium to the analyst consensus target price of 0.00.
Analysts covering Apollo Hospitals Enterprise currently have a consensus Earnings Per Share (EPS) forecast of 4.213 for the next financial year.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Apollo Hospitals Enterprise. Over the past six months, the relative strength of its shares against the market has been 40.93%. At the current price of ₹3058.65, shares in Apollo Hospitals Enterprise are trading at 54.34% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Apollo Hospitals Enterprise PE ratio based on its reported earnings over the past 12 months is 1.87k. The shares are currently trading at ₹3058.65.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Apollo Hospitals Enterprise's management team is headed by:
Here are the top five shareholders of Apollo Hospitals Enterprise based on the size of their shareholding:
